Analysis of Yes-Associated Protein-1 (YAP1) Target Gene Signature to Predict Progressive Breast Cancer

Breast cancers are treated according to the ER/PR or HER2 expression and show better survival outcomes with targeted therapy. Triple-negative breast cancers (TNBCs) with a lack of expression of ER/PR and HER2 are treated with systemic therapy with unpredictable responses and outcomes. It is essentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatasubramanian, Gomathi, Kelkar, Devaki A., Mandal, Susmita, Jolly, Mohit Kumar, Kulkarni, Madhura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999906/
https://www.ncbi.nlm.nih.gov/pubmed/35407556
http://dx.doi.org/10.3390/jcm11071947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999906/
https://www.ncbi.nlm.nih.gov/pubmed/35407556
http://dx.doi.org/10.3390/jcm11071947

Ejemplares similares